Furthermore, our results suggested that the observed increased proliferation rates are caused by a major defect in the early G2/M checkpoint activation in the context of cancer, leading in ARID1A‐deficient EC cells to impaired cell cycle arrest, which, under non‐pathological conditions, should delay cell cycle progression to allow the resolution of mutations or DNA damage. This evidence concerns the gene ARID1A and cancer.